Intensity Therapeutics Valuation
| INTS Stock | 0.25 0.03 13.64% |
Intensity Therapeutics seems to be undervalued based on Macroaxis valuation methodology. Our model calculates the value of Intensity Therapeutics from evaluating the firm fundamentals such as Shares Owned By Insiders of 8.33 %, return on asset of -1.02, and Return On Equity of -2.35 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Intensity Therapeutics' valuation include:
Undervalued
Today
Please note that Intensity Therapeutics' price fluctuation is abnormally volatile at this time. Calculation of the real value of Intensity Therapeutics is based on 3 months time horizon. Increasing Intensity Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Intensity stock is determined by what a typical buyer is willing to pay for full or partial control of Intensity Therapeutics Common. Since Intensity Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Intensity Stock. However, Intensity Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.25 | Real 0.91 | Target 2.9 | Hype 0.27 | Naive 0.2 |
The intrinsic value of Intensity Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Intensity Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Intensity Therapeutics Common helps investors to forecast how Intensity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Intensity Therapeutics more accurately as focusing exclusively on Intensity Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Intensity Therapeutics' intrinsic value based on its ongoing forecasts of Intensity Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Intensity Therapeutics' closest peers.
Intensity Therapeutics Cash |
|
Intensity Therapeutics Total Value Analysis
Intensity Therapeutics Common is currently anticipated to have valuation of 8.08 M with market capitalization of 13.42 M, debt of 138 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Intensity Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.08 M | 13.42 M | 138 K |
Intensity Therapeutics Asset Utilization
One of the ways to look at asset utilization of Intensity is to check how much profit was generated for every dollar of assets it reports. Intensity Therapeutics retains a negative application of resources of -1.02 (percent), losing 0.0102 for each of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each of resources it retains. Simply put, asset utilization of Intensity Therapeutics Common shows how discouraging it operates for each spent on its resources.Intensity Therapeutics Profitability Analysis
Based on Intensity Therapeutics' profitability indicators, Intensity Therapeutics Common may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Intensity Therapeutics' ability to earn profits and add value for shareholders.Net Loss | First Reported 2020-12-31 | Previous Quarter -2.5 M | Current Value -2.7 M | Quarterly Volatility 1 M |
For Intensity Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Intensity Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Intensity Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Intensity Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Intensity Therapeutics over time as well as its relative position and ranking within its peers.
Intensity Therapeutics Earnings per Share Projection vs Actual
By analyzing Intensity Therapeutics' earnings estimates, investors can diagnose different trends across Intensity Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Intensity Therapeutics Common is based on EPS before non-recurring items and includes expenses related to employee stock options.Intensity Therapeutics Ownership Allocation
Intensity Therapeutics Common has a total of 60.06 Million outstanding shares. Intensity Therapeutics retains 8.33 (percent) of its outstanding shares held by insiders and 7.48 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Intensity Therapeutics Profitability Analysis
Net Loss for the year was (16.27 M) with profit before overhead, payroll, taxes, and interest of 0.About Intensity Therapeutics Valuation
The stock valuation mechanism determines Intensity Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Intensity Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intensity Therapeutics. We calculate exposure to Intensity Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Intensity Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -28.8 K | -30.2 K |
Intensity Therapeutics Current Valuation Indicators
Intensity Therapeutics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Intensity Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Intensity Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Intensity Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Intensity Therapeutics' worth.Additional Tools for Intensity Stock Analysis
When running Intensity Therapeutics' price analysis, check to measure Intensity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics is operating at the current time. Most of Intensity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics' price. Additionally, you may evaluate how the addition of Intensity Therapeutics to your portfolios can decrease your overall portfolio volatility.